Literature DB >> 23569333

Role of T cell death in maintaining immune tolerance during persistent viral hepatitis.

Juan Ramón Larrubia1, Megha Uttam Lokhande, Silvia García-Garzón, Joaquín Miquel, Dolores Subirá, Eduardo Sanz-de-Villalobos.   

Abstract

Virus-specific T cells play an important role in the resolution of hepatic infection. However, during chronic hepatitis infection these cells lack their effector functions and fail to control the virus. Hepatitis B virus and hepatitis C virus have developed several mechanisms to generate immune tolerance. One of these strategies is the depletion of virus-specific T cells by apoptosis. The immunotolerogenic liver has unique property to retain and activate naïve T cell to avoid the over reactivation of immune response against antigens which is exploited by hepatotropic viruses to persist. The deletion of the virus-specific T cells occurs by intrinsic (passive) apoptotic mechanism. The pro-apoptotic molecule Bcl-2 interacting mediator (Bim) has attracted increasing attention as a pivotal involvement in apoptosis, as a regulator of tissue homeostasis and an enhancer for the viral persistence. Here, we reviewed our current knowledge on the evidence showing critical role of Bim in viral-specific T cell death by apoptotic pathways and helps in the immune tolerance.

Entities:  

Keywords:  Apoptosis; Apoptotic pathways; Bcl-2 interacting mediator; Hepatitis C virus immune tolerance; Liver tolerance; Specific cytotoxic T lymphocytes; T cell death; Viral hepatitis

Mesh:

Substances:

Year:  2013        PMID: 23569333      PMCID: PMC3613103          DOI: 10.3748/wjg.v19.i12.1877

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  101 in total

Review 1.  Mitochondrial regulation of apoptosis.

Authors:  Bernd Mayer; Rainer Oberbauer
Journal:  News Physiol Sci       Date:  2003-06

2.  Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition.

Authors:  Venu G Pillarisetty; Alaap B Shah; George Miller; Joshua I Bleier; Ronald P DeMatteo
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 3.  Mechanisms of T cell death in the liver: to Bim or not to Bim?

Authors:  Lauren E Holz; David G Bowen; Patrick Bertolino
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

4.  Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1.

Authors:  P F Dijkers; R H Medema; J W Lammers; L Koenderman; P J Coffer
Journal:  Curr Biol       Date:  2000-10-05       Impact factor: 10.834

5.  Generation and characterization of Smac/DIABLO-deficient mice.

Authors:  Hitoshi Okada; Woong-Kyung Suh; Jianping Jin; Minna Woo; Chunying Du; Andrew Elia; Gordon S Duncan; Andrew Wakeham; Annick Itie; Scott W Lowe; Xiaodong Wang; Tak W Mak
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

Authors:  H Tsukuma; T Hiyama; S Tanaka; M Nakao; T Yabuuchi; T Kitamura; K Nakanishi; I Fujimoto; A Inoue; H Yamazaki
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

7.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

8.  The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.

Authors:  David G Bowen; Monica Zen; Lauren Holz; Thomas Davis; Geoffrey W McCaughan; Patrick Bertolino
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

9.  Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction.

Authors:  Christel Gremion; Benno Grabscheid; Benno Wölk; Darius Moradpour; Jürg Reichen; Werner Pichler; Andreas Cerny
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.

Authors:  Pei Zhang; Lilin Zhong; Evi Budo Struble; Hisayoshi Watanabe; Alla Kachko; Kathleen Mihalik; Maria Luisa Virata; Harvey J Alter; Stephen Feinstone; Marian Major
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

View more
  4 in total

Review 1.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

Review 2.  Adaptive immune response during hepatitis C virus infection.

Authors:  Juan Ramón Larrubia; Elia Moreno-Cubero; Megha Uttam Lokhande; Silvia García-Garzón; Alicia Lázaro; Joaquín Miquel; Cristian Perna; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

3.  A Rare Case of Pembrolizumab-Induced Reactivation of Hepatitis B.

Authors:  Anita Pandey; Susan Ezemenari; Maksim Liaukovich; Ivan Richard; Avezbakiyev Boris
Journal:  Case Rep Oncol Med       Date:  2018-10-17

4.  Genome-Wide CRISPR Screen Identifies Host Factors Required by Toxoplasma gondii Infection.

Authors:  Shui-Zhen Wu; Hai-Xia Wei; Dan Jiang; Sheng-Min Li; Wei-Hao Zou; Hong-Juan Peng
Journal:  Front Cell Infect Microbiol       Date:  2020-01-22       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.